PolistenaB., SpandonaroF., CapraR., FantacciniS., SantoniL., ZimatoreG. and GasperiniC. (2019) “The societal impact of treatment with natalizumab of relapsing–remitting multiple sclerosis in Italian clinical practice: The Tysabri® PharmacoEconomics (TyPE) Study”, Global & Regional Health Technology Assessment, 6(1). doi: 10.33393/grhta.2019.463.